Understanding these pathways, their interconnections, and the crosstalk between them and TLR4/MD‐2 is essential for guiding the development of pharmacologically active molecules that could specifically modulate the inflammatory response, paving the way to new strategies for combating immune‐mediated diseases and resistant infections. Here, TLR4 is linked to infection.